The information contained on this global HIPRA website is not intended for audiences in all countries.
General, scientific or technical information about HIPRA products or services is not intended for commercial promotion.
For specific information on the products or services available in your country, please filter by the corresponding country.
Live heterologous vaccine against myxomatosis, in injectable freeze-dried tablet.
HIPRA University offers high quality training programmes in strategic areas of interest for professionals
Access an advanced diagnostic service with maximum comfort and reliability
Discover our latest news